Advances in Diagnosis and Treatment of Neuroendocrine Neoplasms

To have your paper considered for this Special Collection, submit by October 31, 2023.

Please review the Manuscript Submission Guidelines before submitting your paper.

Guest Editors:

Co-Guest Editors:Dr. Rachel Riechelmann

• Head - Clinical Oncology Department
• Medical Oncologist and Researcher - Colorectal cancer & NET
• AC Camargo Cancer Center, Sao Paulo, Brazil

Dr. Mairead Mcnamara

• Senior Lecturer, University of Manchester, UK
• Honorary Consultant in Medical Oncology at The Christie NHS Foundation Trust, UK

Aims & Scope:

Neuroendocrine neoplasms (NNEs) comprise a heterogenous and fascinating group of cancers that attract scientific investigation. In fact, numerous recent clinical research endeavors have been undertaken in the field of NNE, including phase III trials. However, there are still many unanswered questions in the diagnosis and therapeutic management of NNEs. This issue of Therapeutic Advances in Medical Oncology seeks studies that address new diagnostic tools and advances in the treatment of patients with NNE. The Guest Editors encourage original research submissions to join related invited review articles on topics, including but not limited to:

• New molecular clinically oriented diagnostic markers (somatic and germline)
• Therapeutic sequencing in metastatic disease
• Clinical Trials
• New prognostic and predictive markers
• Immunotherapy in NNE

Submission information:

Please contact the Managing Editor Georgia Patey for pre-submission enquiries on georgia.patey@sagepub.co.uk

Manuscript deadline: 31 October 2023

Click here to submit your paper.

Tags： call for paper：Therapeutic Advances in Medical Oncology（截至2023年10月31日）